<<

CLINICAL COMPREHENSIVE TESTING AND CONSULTATIVE SERVICES FOR INFECTIOUS DISEASES CLINICAL MICROBIOLOGY AT MAYO

WHY MAYO CLINIC? Mayo Clinic’s internationally-renowned PERFORMING THE RIGHT TESTS, clinical microbiology laboratories span all NOT THE MOST TESTS areas of conventional and molecular , offering a broad selection of tests JUST LIKE YOU, WE ARE CARE PROVIDERS. WE TREAT EVERYDAY, AND OUR SERVICES ENABLE designed for rapid identification and in depth INSTITUTIONS TO: characterization of the causative agents of infectious diseases. } Apply care-driven testing approaches } Establish clinically proven test utilization strategies Our laboratories perform over 3 million tests } Collaborate with Mayo Clinic , annually and have developed and implemented , and laboratory professionals culture techniques; immunoassays; antimicrobial } Advance the integration of community health susceptibility testing; and molecular methods care delivery for rapid detection, identification, and characterization; and provision treatment guidance for microbial . THE MAYO MEDICAL LABORATORIES DIFFERENCE

Every laboratory offers testing; but, at Mayo Medical CONSULTANT-LED Laboratories, we offer a service that allow patients SUBSPECIALTY LABORATORIES access to Mayo Clinic experts from across the world in addition to our comprehensive testing menu. BACTERIOLOGY Our clinicians and laboratorians focus on maintaining high-quality, cost-effective, and HEPATITIS/HIV MOLECULAR efficient care by using algorithmic, evidence-based approaches that lead to correct diagnoses and HEPATITIS/HIV treatment, while minimizing unnecessary testing. More importantly, our laboratories are managed by INFECTIOUS DISEASE SEROLOGY physicians and scientists with expert knowledge regarding the clinical implications of each test result and how it can impact patient care. MYCOBACTERIOLOGY

MYCOLOGY

PARASITOLOGY

VIROLOGY

MAYOMEDICALLABORATORIES.COM/MICROBIOLOGY TESTING CATEGORIES

Mayo Medical Laboratories offers a full menu of tests for the detection and identification of infectious diseases.

ANTIMICROBIAL SUSCEPTIBILITY HIV } Phenotypic and genotypic antimicrobial } Serologic and molecular testing, including antiviral susceptibility testing of , mycobacteria, resistance, for HIV-1 and HIV-2 and fungal isolates POST- CNS } Full panel of tests for screening following } Extensive nucleic acid amplification testing, culture, immunization and serologic testing INFECTIONS OF AND THE NEONATE CYSTIC FIBROSIS } Extensive PCR and serology panels } Specialized bacterial respiratory culture as well INFECTIONS OF THE IMMUNOCOMPROMISED as mycobacterial and fungal respiratory culture } Extensive nucleic acid amplification testing, culture, including organism identification and serologic testing ENDOCARDITIS ORGANISM IDENTIFICATION } Nucleic acid amplification tests, culture, and } Extensive nucleic acid amplification and serology serologic tests for common and uncommon testing organisms PREVENTION AND SURVEILLANCE FOR INFECTIOUS DISEASE OF UNKNOWN ORIGIN } Detection of nosocomial-acquired infections, } Extensive nucleic acid amplification testing, culture, antimicrobial susceptibility testing, bacterial strain and serologic testing typing by whole genome sequencing for outbreak GASTROINTESTINAL INFECTIONS detection and monitoring } Nucleic acid amplification panel for common TRAVELER ASSOCIATED INFECTIONS stool pathogens, as well as individual nucleic acid }  nucleic acid amplification testing (including amplification tests for selected pathogens knowlesi), full parasite exam from } T. whipplei PCR blood and stool GENITOURINARY INFECTIONS AND UPPER AND LOWER RESPIRATORY INFECTIONS SEXUALLY TRANSMITTED INFECTIONS } Full culture and nucleic acid amplification testing } Nucleic acid amplification testing on multiple specimen sources and serologic testing -BORNE DISEASES } Nucleic acid amplification testing and serologic HEPATITIS testing, including panels for and tick- } Serologic and molecular testing for viral hepatitis borne diseases agents (A, B, C, D, E) } Antiviral testing for HCV

800-533-1710 or +507-266-5700 LABORATORY DIRECTORS

ROBIN PATEL, M.D. NANCY L. WENGENACK, PH.D. Division Chair Mycobacteriology Biofilm-related infections Mycology Molecular bacteriology Antimycobacterial and antifungal Sequencing-based bacteriology susceptibility testing

MATTHEW J. BINNICKER, PH.D. JOSEPH D. YAO, M.D. Molecular virology Hepatitis viruses Viral infections in transplant recipients Viral respiratory infections virus (HIV) Hepatitis and HIV antiviral susceptibility testing

BOBBI S. PRITT, M.D. JANE J. HATA, PH.D. Parasitology Laboratory Director, Florida Vector-borne diseases Clinical Microbiology and Serology Infectious Diseases anatomic

AUDREY SCHUETZ, M.D. THOMAS E. GRYS, PH.D. Anaerobic bacteriology Laboratory Director, Arizona Antibacterial susceptibility testing Clinical Microbiology Infectious diseases anatomic pathology

ELITZA S. THEEL, PH.D. Detection of antibodies against infectious agents Detection of infectious diseases antigens Vector-borne diseases

FOR MORE INFORMATION ABOUT MICROBIOLOGY AND INFECTIOUS DISEASE TESTING, VISIT: MayoMedicalLaboratories.com/microbiology

mayomedicallaboratories.com news.mayomedicallaboratories.com /mayocliniclabs @mayocliniclabs

MC2775-12rev0518